About Rachel

Rachel Brummert is Founder and CEO of Courage to Continue, LLC and serves as a Special Government Employee (SGE) at the U.S. Food and Drug Administration. She is also a contributor for Drugwatch and Medshadow Foundation. Additionally, she is Communications Lead at American Society of Pharmacovigilance and founding member of the STRIPE Initiative.

Her resume can be found here.

Rachel began her journey in healthcare advocacy in 2006 when she suffered permanent adverse reactions from a commonly prescribed antibiotic called Levaquin. She used her experience as a harmed patient to advocate for others and works in partnership with established consumer advocacy groups and agencies whose work centers around patient safety. In addition, she collaborates with the Centers for Disease Control and Prevention (CDC) about infection control and patient safety.

She uses her passion for being a voice for the voiceless through film making, webinars, hosting virtual series, and public speaking.